Form 4: Bio-Key International CEO Michael DePasquale Acquires Shares Under Employee Stock Purchase Plan
SEC Form 4 Filing
Michael DePasquale, CEO of Bio-Key International, acquired 139 shares of common stock under the company's Employee Stock Purchase Plan at a price of $1.394 per share.
Summary
- On June 28, 2024, Michael DePasquale, the CEO and Chairman of Bio-Key International, acquired 139 shares of common stock.
- The shares were purchased under the company's 2021 Employee Stock Purchase Plan.
- The purchase price was $1.394 per share.
- Following the transaction, DePasquale directly owns 15,380 shares of Bio-Key International.
- All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
- Holdings do not include options to purchase 464 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction under an employee stock purchase plan. While insider buying can be seen as a positive signal, the small number of shares acquired doesn't suggest a strong bullish outlook.
Positives
- The CEO's participation in the Employee Stock Purchase Plan could be viewed positively as it aligns his interests with those of the shareholders.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. Purchases by company executives can sometimes be interpreted as a sign of confidence in the company's future prospects, but should be considered in the context of the executive's overall compensation and investment strategy.
Comparison to Industry Standards
- It is common for executives to participate in employee stock purchase plans.
- The amount of shares acquired is relatively small, suggesting it is a routine transaction rather than a major investment decision.
- Comparable companies such as Aware, Inc. and Identiv, Inc. also have executives who regularly report transactions in their company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It may slightly boost investor confidence due to the CEO's participation in the stock purchase plan.
Key Dates
| Date | Description |
|---|---|
| December 21, 2023 | Effective date of BIO-key's 1-for-18 reverse stock split. |
| June 28, 2024 | Date of the transaction where Michael DePasquale acquired 139 shares. |
| July 02, 2024 | Date of signature on the Form 4 filing. |
Keywords
BIO-key International, Michael DePasquale, Employee Stock Purchase Plan, Form 4, Insider Trading, Stock Acquisition, BKYI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.